R. Sanders Williams - 19 May 2023 Form 4 Insider Report for AMGEN INC (AMGN)

Reporting relationship: Director
Issuer ticker: AMGN
Reported as of: 19 May 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 23 May 2023, 19:29:19 UTC
Prior SEC filing: 14 Feb 2023
Next SEC filing: 12 Jun 2023
Source filing: View source filing
Reporting owner signature: /s/ R. Sanders Williams

Key filing fact

R. Sanders Williams filed Form 4 for AMGEN INC (AMGN) on 23 May 2023.

Key facts

This page summarizes R. Sanders Williams's Form 4 filing for AMGEN INC (AMGN).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 23 May 2023, 19:29.

Change

Previous filing in this sequence was filed on 14 Feb 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AMGN transaction

Common Stock

Award

Transaction value: $0
Shares: +939
Change %: +18%
Price: $0.000000
Shares after: 6,240
Date: 19 May 2023
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule.